Sodium Iodide I 131

Radnostix, Inc. has initiated a Class III voluntary recall (D-0401-2026) for 2,699 blister cartons of its Gelatin Capsule Pack, intended for use with the SODIUM IODIDE I-131 Kit, due to failed tablet/capsule specifications. This nationwide recall from their Idaho Falls, ID facility underscores critical quality control challenges for ancillary drug components, impacting supply chain reliability.

Radnostix, Inc. has initiated a Class II recall for 16 units of Sodium Iodide I-131 Solution, Therapeutic Oral, manufactured by International Isotopes Inc. in Idaho Falls, ID. This voluntary action, prompted by particulate matter from production issues, necessitates immediate review of radiopharmaceutical supply chains. Procurement and regulatory teams must assess quality control and supply continuity risks for this critical therapeutic agent.